ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,442Medicare Part D Prescriptions Filled, Including Refills

Rank: 753 out of 5176

$565K Total Retail Price of All Prescriptions

Rank: 913 out of 5176

430 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 6,362 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 587 420 1 1
METOPROLOL SUCCINATE 439 343 2 11
AMLODIPINE BESYLATE 400 339 3 2
SYNTHROID 324 130 4 33
HYDROCHLOROTHIAZIDE 280 223 5 10
ATORVASTATIN CALCIUM 238 162 6 9
METFORMIN HCL 229 162 7 7
OMEPRAZOLE 210 123 8 3
TAMSULOSIN HCL 189 104 9 20
TRICOR 181 73 10 148
QUINAPRIL HCL 170 134 11 82
ALENDRONATE SODIUM 153 52 12 18
LISINOPRIL 143 131 13 5
GLIMEPIRIDE 134 96 14 37
CRESTOR 129 115 15 15
LOSARTAN POTASSIUM 126 103 16 14
FUROSEMIDE 121 69 17 8
FLUTICASONE PROPIONATE 96 54 18 38
FINASTERIDE 95 53 19 69
LEVOTHYROXINE SODIUM 94 81 20 4
METOPROLOL TARTRATE 90 59 21 6
CLOPIDOGREL 89 87 22 26
PLAVIX 88 84 23 29
SERTRALINE HCL 84 53 24 30
ZOLPIDEM TARTRATE 83 80 25 17
LACTULOSE 81 19 26 87
ISOSORBIDE MONONITRATE ER 80 80 27 44
PRAVASTATIN SODIUM 80 34 27 23
PANTOPRAZOLE SODIUM 78 60 29 61
LIPITOR 77 52 30 51
DONEPEZIL HCL 76 76 31 28
LOSARTAN-HYDROCHLOROTHIAZIDE 73 49 32 35
FAMOTIDINE 71 36 33 58
PEG 3350-ELECTROLYTE 66 0 34 652
POLYETHYLENE GLYCOL 3350 66 20 34 74
JANUVIA 65 59 36 25
SPIRONOLACTONE 65 55 36 88
BENAZEPRIL HCL 64 60 38 131
ATENOLOL 63 44 39 12
OXYBUTYNIN CHLORIDE ER 62 39 40 204
ENALAPRIL MALEATE 61 33 41 22
ZETIA 57 23 42 68
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 53 43 49
AMLODIPINE BESYLATE-BENAZEPRIL 53 50 43 55
VYTORIN 51 51 45 152
PROPRANOLOL HCL 50 33 46 199
ALLOPURINOL 50 28 46 41
WARFARIN SODIUM 50 50 46 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.